
    
      The study will consist of the following periods: Screening (Days -21 to -1), Transplant (Day
      0), Post-Transplant (Day 0/post-skin closure through 12 months post-transplant). All subjects
      will enter into a Screening Period (Days -21 to -1 prior to transplant), undergo a Transplant
      (Day 0 [zero]), and are then to be followed for up to 12 months in the Post-Transplant Period
      (Day 0 through 12 months post-transplant).
    
  